Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide

Overview

Study Objective: The purpose of this study is to compare the effects of metoclopramide administration in bolus versus slow infusion medications in ED patients complaining of nausea for the determination of the therapeutic effect and prevention of akathisia. Methods: This was a prospective, randomized, double-blind trial. The investigation was held between 01 March 2007 and 01 May 2008, in the Emergency Department of Pamukkale University Faculty of Medicine. The patients with moderate to severe nausea randomized and divided into two groups as for the previously planned administration type of drug. Ten mg metoclopramide was administered in one group with slow infusion (SIG) in 15 minutes, via 2 minutes bolus infusion (BIG) into the other group. Whole procedure was observed, akathisia and nausea scores and vital changes were recorded.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: Triple (Participant, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: March 2007

Interventions

  • Drug: metoclopramide 10 mg

Arms, Groups and Cohorts

  • Active Comparator: 2 minutes bolus infusion
  • Active Comparator: 15 minutes slow infusion

Clinical Trial Outcome Measures

Primary Measures

  • akathisia and nausea scores

Participating in This Clinical Trial

Inclusion Criteria

  • Patients 18 through 65 years of age and 50-90 kg of weight who presented to the ED with primary or secondary complaints of moderate to severe nausea who not use of commonly accepted antiemetic within the previous 24 hours were eligible for this study. – Their peripheral oxygen saturation level was 90% or over while respirating room air and free of any respiratory problems. Exclusion Criteria:

  • Patients with mild symptoms of nausea – Altered mental status – Abnormal vital signs – Any known allergy to the metoclopramide – Previously enrolled in the study – Known renal failure or insufficiency – GIS hemorrhage, ileus and/or perforation – Women who were pregnant and lactating – Those with a history of epilepsy – Admitted to the ED due to acute psychiatric symptoms – Restless legs syndrome – Parkinson – Organic brain disease – Phaeochromocytoma – Patient with alcohol – Anticholinergic, sedative, hypnotic, trankilizan, digoxin, cimetidine, tetracycline and levo-dopa use – Presence of severe agitation akathisia can not be evaluated and uncooperative individuals.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 65 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Pamukkale University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.